A new series of cyclic amino acids as inhibitors of S-adenosyl L- methionine synthetase

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 13, 1998, Pages 1629-1634

  Lavrador, Karine ^a   Guillerm, Danielle ^a   Guillerm, Georges ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Amino acids derivatives; Enzyme inhibitors; Kinetics

Indexed keywords

3 AMINO 3 (TETRAHYDROFURANYL) CARBOXYLIC ACID; 3 AMINO 3 (TETRAHYDROTHIENYL) CARBOXYLIC ACID; ADENOSYLHOMOCYSTEINASE; AMINO ACID DERIVATIVE; ENZYME INHIBITOR; METHIONINE DERIVATIVE; METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; METHYLATION;

AMINO ACIDS, CYCLIC; ANIMALS; ENZYME INHIBITORS; HYDROGEN-ION CONCENTRATION; KINETICS; LIVER; METHIONINE ADENOSYLTRANSFERASE; RATS; RECOMBINANT PROTEINS;

EID: 0032493484     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00267-4     Document Type: Article

References (25)

1. 1. Cantoni, G.L. J. Biol. Chem., 1953, 204, 403.
2. 2. Biochemistry of S-adenosylmethionine and related compounds; Usdin, E. ; Borchardt, R. T. ; Creveling,. C.R., Ed., Macmillan & Co : London, 1982.
3. 3. Cantoni, G.L ; Chiang, P.K. In Natural Sulfur compounds: novel biochemical and structural aspecst, Cavallini, D., Gauld, G.E., Zappia, V., Ed., Plenum Publishing Corp : New York, 1980,pp 67-80.
4. 4. (a) Porter, C.W. ; Sufrin, J.R. Anticancer Res. 1986, 6, 525.
5. (b) Sufrin, J.R. ; Lombardini, J.B. ; Alks, V. Biochem. Biophys. Acta, 1992. 1202, 87.
6. (c) Peeg, A.E.. Cancer Res., 1988, 48, 759.
7. 5. (a) Liu, S. ; Wolfe, M.S. ; Borchardt, R.T. Antiviral Res., 1992, 19, 247.
8. (b) Yuan, C.S. ; Liu, S. ; Wnuk, S.F. ; Robins, M.J. ; Borchardt, R.T. Nucleosides & Nucleotides 1995, 14, 439.
9. 6. Kramer, D.L. ; Porter, C.W. ; Borchardt, R.T. ; Sufrin, J.R. Cancer. Res. 1990, 50, 3828.
10. (b) Ishii, H. ; Hasobe, M. ; McKee, J.G. ; Ault-Riche, D.B ; M., Borchardt, R.T., Antiviral Chem. & Chemother. 1993, 4, 127.
11. 7. a) Lombardini, J.B. ; Coulter, A.W. ; Talalay, P. Mol. Pharmacol. 1970, 4, 481.
12. (b) Coulter, A.W. ; Lombardini, J.B. ; Talalay, P. Mol. Pharmacol. 1974, 10, 29.
13. (c) Coulter, A.W. ; Lombardini, J.B. ; Talalay, P. Mol. Pharmacol. 1974, 10, 319.
14. (d) Sufrin, J.R. ; Coulter, A.W. ; Talalay, P. Mol. Pharmacol. 1979, 15, 661.
15. (e) Sufrin, J.R. In Transmethylation ; Usdine, I. ; Borchardt, R.T., Creveling,. C.R., Ed. , Elsevier North Holland, 1979, p 27.
16. 8. Sufrin, J.R. ; Lombardini, J.B. ; Keith, D.D. Biochem. Biophys. Res. Com. 1982, 106, 25.
17. 9. (a) Alks, V. ; Sufrin, J.R. Tet. Lett. 1990, 37, 5257.
18. (b) Alks, V. ; Keith, D.D. , Sufrin, J.R. Synthesis 1992, 623.
19. 10. a) Bucherer, H.T. ; Steiner, W. J. Prakt Chem. 1934, 140, 291.
20. (b) Bucherer, H.T. ; Liev, V.A. J. Prakt Chem. 1934, 141, 5.
21. 2H).
22. 12 Chen, S.T ; Wang, K.T. ; Wong, G.H. J. Chem. Commun. 1986, 1514.
23. 2. The absolute configuration of hydrolysed product was not determined. Since it is too hasardous to assume the stereospecificity of Alcalase towards natural AAs is the same that for α,α-substituted AAs like Ib or IIc, (+) and (-) enantiomers obtained were tested on the enzyme, only (+) enantiomers have significant inhibitory property.
24. 14. Alvarez, L. ; Mingorance, J. ; Pajares, M.A. ; Mato, J.M. Biochem. J. 1994, 301, 557.
25. 15 Sullivan, D.M. ; Hoffman, J.L. Biochemistry 1983, 22, 1636.